Black Rock Inc. Blueprint Medicines Corp Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Black Rock Inc. holds 6,647,297 shares of BPMC stock, worth $861 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,647,297
Previous 6,447,461
3.1%
Holding current value
$861 Million
Previous $612 Million
17.14%
% of portfolio
0.02%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding BPMC
# of Institutions
400Shares Held
67.3MCall Options Held
973KPut Options Held
1.54M-
Vanguard Group Inc Valley Forge, PA6.42MShares$831 Million0.01% of portfolio
-
Pentwater Capital Management LP Naples, FL3.9MShares$505 Million3.34% of portfolio
-
Jpmorgan Chase & CO New York, NY2.51MShares$324 Million0.02% of portfolio
-
State Street Corp Boston, MA2.23MShares$289 Million0.01% of portfolio
-
Ubs Group Ag2.17MShares$281 Million0.05% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.73B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...